Search research articles
Contact Us
Filters
Showing results (31-40 of 112) with videos related to
Page
of 12
Sort By:
JCI Insight
|
December 9, 2025
Enhanced lipid metabolism serves as a metabolic vulnerability to polyunsaturated fatty acids in glioblastoma
Shiva Kant, Yi Zhao, Pravin Kesarwani, et al.
Nature Communications
|
February 3, 2016
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma
Juli R Bagó, Adolfo Alfonso-Pecchio, Onyi Okolie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 14, 2020
Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients
Andrew Buckley, Shaye B Hagler, Vivien Lettry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 24, 2014
Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process
Rui Pedro Galvao, Anita Kasina, Robert S McNeill, et al.
Journal of Visualized Experiments : Jove
|
August 23, 2014
Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice
Robert S McNeill, Ralf S Schmid, Ryan E Bash, et al.
Life Science Alliance
|
July 12, 2022
PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance
Kevin Tabury, Mehri Monavarian, Eduardo Listik, et al.
Nanomedicine (London, England)
|
September 28, 2017
Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer
Andrew J Madden, Bruce Oberhardt, Dustin Lockney, et al.
Analytical Biochemistry
|
January 30, 2002
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro
C Ryan Miller, Allen N Gustin, Donald J Buchsbaum, et al.
American Journal of Clinical Oncology
|
April 1, 2008
A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer
Boone Goodgame, Avinash Viswanathan, C Ryan Miller, et al.
Genes & Cancer
|
January 4, 2014
The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation
Lauren P Huff, Molly J Decristo, Dimitri Trembath, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 112) with videos related to
Sort By:
Page
of 12
JCI Insight
|
December 9, 2025
Enhanced lipid metabolism serves as a metabolic vulnerability to polyunsaturated fatty acids in glioblastoma
Shiva Kant, Yi Zhao, Pravin Kesarwani, et al.
Nature Communications
|
February 3, 2016
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma
Juli R Bagó, Adolfo Alfonso-Pecchio, Onyi Okolie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 14, 2020
Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients
Andrew Buckley, Shaye B Hagler, Vivien Lettry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 24, 2014
Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process
Rui Pedro Galvao, Anita Kasina, Robert S McNeill, et al.
Journal of Visualized Experiments : Jove
|
August 23, 2014
Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice
Robert S McNeill, Ralf S Schmid, Ryan E Bash, et al.
Life Science Alliance
|
July 12, 2022
PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance
Kevin Tabury, Mehri Monavarian, Eduardo Listik, et al.
Nanomedicine (London, England)
|
September 28, 2017
Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer
Andrew J Madden, Bruce Oberhardt, Dustin Lockney, et al.
Analytical Biochemistry
|
January 30, 2002
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro
C Ryan Miller, Allen N Gustin, Donald J Buchsbaum, et al.
American Journal of Clinical Oncology
|
April 1, 2008
A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer
Boone Goodgame, Avinash Viswanathan, C Ryan Miller, et al.
Genes & Cancer
|
January 4, 2014
The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation
Lauren P Huff, Molly J Decristo, Dimitri Trembath, et al.
Page
of 12